A detailed history of Simplex Trading, LLC transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Simplex Trading, LLC holds 5,741 shares of MGTX stock, worth $36,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,741
Previous 4,756 20.71%
Holding current value
$36,053
Previous $20,000 15.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$3.88 - $5.23 $3,821 - $5,151
985 Added 20.71%
5,741 $23,000
Q2 2024

Jul 25, 2024

BUY
$4.21 - $5.81 $6,041 - $8,337
1,435 Added 43.21%
4,756 $20,000
Q1 2024

Apr 25, 2024

SELL
$5.78 - $7.33 $168,157 - $213,251
-29,093 Reduced 89.75%
3,321 $20,000
Q4 2023

Feb 02, 2024

BUY
$3.6 - $7.15 $116,690 - $231,760
32,414 New
32,414 $227,000
Q2 2023

Aug 04, 2023

BUY
$5.19 - $8.07 $41,545 - $64,600
8,005 Added 882.58%
8,912 $59,000
Q1 2023

Apr 27, 2023

SELL
$5.04 - $8.6 $6,552 - $11,180
-1,300 Reduced 58.9%
907 $4,000
Q4 2022

Feb 02, 2023

BUY
$5.8 - $8.98 $12,800 - $19,818
2,207 New
2,207 $14,000
Q2 2022

Aug 03, 2022

SELL
$6.8 - $14.23 $43,261 - $90,531
-6,362 Reduced 76.72%
1,931 $14,000
Q1 2022

May 02, 2022

BUY
$13.42 - $23.38 $55,451 - $96,606
4,132 Added 99.3%
8,293 $114,000
Q4 2021

Feb 23, 2022

BUY
$12.78 - $23.74 $46,813 - $86,959
3,663 Added 735.54%
4,161 $98,000
Q3 2021

Oct 28, 2021

SELL
$11.73 - $16.08 $4,692 - $6,431
-400 Reduced 44.54%
498 $7,000
Q2 2021

Aug 12, 2021

BUY
$12.85 - $16.2 $11,539 - $14,547
898 New
898 $13,000
Q4 2020

Feb 02, 2021

SELL
$12.4 - $17.6 $1,240 - $1,760
-100 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$11.59 - $14.93 $1,159 - $1,493
100 New
100 $1,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $283M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.